Roble, Belko & Company, Inc Viatris Inc Transaction History
Roble, Belko & Company, Inc
- $629 Million
- Q4 2024
A detailed history of Roble, Belko & Company, Inc transactions in Viatris Inc stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 327 shares of VTRS stock, worth $3,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
327
Previous 66
395.45%
Holding current value
$3,642
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VTRS
# of Institutions
1,093Shares Held
966MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.57 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.03 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$703 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$698 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$543 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...